Disomotide Completed Phase 1 Trials for Melanoma Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured |